::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

USE OF NEUROPEPTIDES IN ASTHMA AND CYSTIC FIBROSIS IN PAKISTAN

AUTHORS:

Dr. Muhammad Umar, Dr. Zaryab Ahmad Chohan, Dr. Muhammad Ahsen Arif

ABSTRACT:

Introduction: Lung diseases are among the top 5 mortality-causing diseases in the World. As with many organs, lung diseases vary significantly in their etiology and pathology, ranging from inherited genetic diseases like cystic fibrosis (CF), to allergic and inflammatory disorder diseases, such as asthma and chronic obstructive pulmonary disease (COPD). Objectives of the study: The basic aim of the study is to analyze the use of neuropeptides in asthma and cystic fibrosis disease in Pakistan. Methodology of the study: This study was conducted at Allama Iqbal Memorial Teaching Hospital Sialkot during 2019. This study was conducted with the permission of ethical committee of hospital. In this study we analyze the use of different neuropeptide drugs for asthma and chronic obstructive pulmonary disease. Results: Asthma and COPD are common, chronic, and heterogeneous pulmonary diseases that have a significant impact on quality of life. Asthma is primarily viewed as an inflammatory disorder of the airways and often is diagnosed at young age. It is characterized by wheezing, cough, chest tightness and variable airflow limitation that is partially reversible. Conclusion: It is concluded that Neuropeptides continue to be a source of insight and complexity when it comes to airway disease.